Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
Related Posts
Deleija JD, Shah SZ, Felzer J, Tan X, Garvey C, DeCato TW, Pennington K, Sehgal S, Kennedy C, Kumar A. Pulmonary Rehabilitation Referral Practice Patterns[...]
Wannaphut C, Tanariyakul M, Yoshikawa GT, Hernandez BY, Villanueva NA, Acoba JD. Survival disparities in non-small cell lung cancer: Disaggregating Asians from NHPI and identifying[...]
Shah KG, Adler SG, Dai T, Nast CC. Calcific Changes in an End-Stage Kidney following Long-Term Dialysis, Tertiary Hyperparathyroidism, and Treatment for Complement-Mediated Thrombotic Microangiopathy:[...]